ArticleACS pharmacology & translational science2021

Peripherally Selective CB1 Receptor Antagonist Improves Symptoms of Metabolic Syndrome in Mice.

Nayaab Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.